http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-201600364-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C279-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-53 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C279-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 |
| filingDate | 2014-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EA-201600364-A1 |
| titleOfInvention | 2-METHYLSULFANIL-6-NITRO-7-OXO-1,2,4-TRIAZOLO [5,1-C] [1,2,4] TRIAZINID L-ARGININIA DIHYDRATE, HAVING ACTIVITY, METHOD FOR ITS PREPARATION AND APPLICATION OF PREVENTION AND PREVENTION WESTERN NEIL FEVER |
| abstract | The claimed invention relates to the field of biologically active compounds and relates to 2-methylsulfonyl-6-nitro-7-oxo-1,2,4-triazolo [5,1c] [1,2,4] triazinide L-arginine dihydrate, which has antiviral effect intended for the treatment and prevention of viral diseases of humans and animals, mainly West Nile Fever, and can be used in the chemical and pharmaceutical industry, research laboratories, hospitals, and veterinary medicine. The technical result, the achievement of which the claimed invention is directed, is the creation of a new effective means of the azoloazine series, which has antiviral activity against a group of RNA-containing viruses, and a decrease in the dependence of the active compound on cellular metabolism. This technical result is achieved by the creation of a new drug 2-methylsulfanyl-6-nitro-7-oxo-1,2,4-triazolo [5,7-c] [1,2,4] triazinide L-arginine dihydrate, having an antiviral effect and having the formula: The above technical result is achieved by the fact that the method of producing 2-methylsulfanyl-6-nitro-7-oxo-1,2,4-triazolo [5,1-c] [1,2,4] triazinide L- arginine dihydrate involves mixing arginine dissolved in water and dissolved (1: 1) in water-ethanol mixture (1: 1) and then the resulting mixture is boiled, then cooled, the precipitated precipitate is filtered off and dried. |
| priorityDate | 2013-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 23.